US 11529363
Methods of treating cancer in pediatric patients
granted A61KA61K31/475A61K31/519
Quick answer
US patent 11529363 (Methods of treating cancer in pediatric patients) held by Takeda Pharmaceutical Company Limited expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61K, A61K31/475, A61K31/519, A61K31/573, A61K31/675